Emerging Green Chemistry Market Ushers in a New Era of Sustainable Pharmaceutical Manufacturing
December 17, 2024 05:00 ET
|
Research and Markets
Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big...
Global Breakthrough Therapy Designation Market Set to Double by 2029 with Notable CAGR of 13.80%
December 13, 2024 11:02 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Breakthrough Therapies: Market Dynamics and Investment Opportunities" report has been added to ResearchAndMarkets.com's offering.The Breakthrough...
Growth Trends in the Pharmaceutical Drying Equipment Market, 2024-2029: Increased Market Competition and High Demand for Generic & Biosimilar Drugs
December 10, 2024 10:46 ET
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drying Equipment Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The Pharmaceutical Drying...
GCC Pharmaceutical Market Clinical Trials Outlook 2030 - Branded & Imported Drug Dominate GCC Pharmaceutical Market Landscape
December 06, 2024 08:54 ET
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering. The Gulf...
KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer
December 05, 2024 09:00 ET
|
KRTL Holding Group
Lakewood, CO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces that its subsidiary, KRTL Biotech Inc., has successfully registered Industria Químico Farmaceutica...
Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering
December 04, 2024 16:56 ET
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
December 02, 2024 19:00 ET
|
Jupiter Neurosciences, Inc.
Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the “Company” or “Jupiter Neurosciences”), a clinical stage pharmaceutical company advancing a...
Scienture Holdings, Inc. Announces Private Placement of $3 Million of 10% Secured Convertible Debentures as Initial Tranche of $12 Million Offering and Entry into $50 Million Equity Line of Credit Agreement
November 26, 2024 16:05 ET
|
Scienture Holdings, Inc.
Scienture Holdings to Receive Funding of Up to $12 Million From Private Placement of 10% Secured Convertible Debentures and Up to $50 Million from Equity Line of Credit Tampa, FL, Nov. 26, 2024 ...
A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)
November 26, 2024 09:00 ET
|
KRTL Holding Group
Lakewood, CO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- KRTL Holding Group, Inc. (OTC: KRTL) announces a major strategic milestone: its subsidiary, KRTL Biotech Inc., has successfully completed the...
Digi-Tech Pharma & AI Conference 2025: Reimagining Pharma by Integrating Science and Technology (London, United Kingdom - May 28-29, 2025)
November 22, 2024 04:07 ET
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Digi-Tech Pharma & AI 2025" conference has been added to ResearchAndMarkets.com's offering. In this 8th edition as we explore the novel...